Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Grimwade

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Leukemia|May 3, 2002
Screening for core binding factor gene rearrangements in acute myeloid leukemiaDavid Grimwade
Best Practice & Research. Clinical Haematology|May 4, 2002
The significance of minimal residual disease in patients with t(15;17)David Grimwade
Best Practice & Research. Clinical Haematology|December 4, 2012
The changing paradigm of prognostic factors in acute myeloid leukaemiaDavid Grimwade
The New England Journal of Medicine|April 16, 2004
Gene-expression profiling in acute myeloid leukemiaDavid Grimwade, Torsten Haferlach
Methods in Molecular Medicine|October 24, 2003
Real-time quantitative RT-PCR to detect fusion gene transcripts associated with AMLRajinder Flora, David Grimwade
Hematology/Oncology Clinics of North America|November 19, 2011
Diagnostic and prognostic value of cytogenetics in acute myeloid leukemiaDavid Grimwade, Krzysztof Mrózek
Blood|July 9, 2016
Just 1 test to diagnose AML?!!Richard Dillon, David Grimwade
Leukemia & Lymphoma|December 10, 2013
Prognostic significance of additional cytogenetic abnormalities and FLT3 mutations in acute promyelocytic leukemiaRichard Dillon, David Grimwade
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2010
Molecular biology of therapy-related leukaemiasMelanie Joannides, David Grimwade
International Journal of Hematology|July 14, 2012
Molecular markers in acute myeloid leukaemiaAndrea Kühnl, David Grimwade
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Leukemia|May 3, 2002
Screening for core binding factor gene rearrangements in acute myeloid leukemiaDavid Grimwade
Best Practice & Research. Clinical Haematology|May 4, 2002
The significance of minimal residual disease in patients with t(15;17)David Grimwade
Best Practice & Research. Clinical Haematology|December 4, 2012
The changing paradigm of prognostic factors in acute myeloid leukaemiaDavid Grimwade
The New England Journal of Medicine|April 16, 2004
Gene-expression profiling in acute myeloid leukemiaDavid Grimwade, Torsten Haferlach
Methods in Molecular Medicine|October 24, 2003
Real-time quantitative RT-PCR to detect fusion gene transcripts associated with AMLRajinder Flora, David Grimwade
Hematology/Oncology Clinics of North America|November 19, 2011
Diagnostic and prognostic value of cytogenetics in acute myeloid leukemiaDavid Grimwade, Krzysztof Mrózek
Blood|July 9, 2016
Just 1 test to diagnose AML?!!Richard Dillon, David Grimwade
Leukemia & Lymphoma|December 10, 2013
Prognostic significance of additional cytogenetic abnormalities and FLT3 mutations in acute promyelocytic leukemiaRichard Dillon, David Grimwade
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2010
Molecular biology of therapy-related leukaemiasMelanie Joannides, David Grimwade
International Journal of Hematology|July 14, 2012
Molecular markers in acute myeloid leukaemiaAndrea Kühnl, David Grimwade
Pageof 11